A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 9, 2025

Primary Completion Date

July 17, 2025

Study Completion Date

July 17, 2025

Conditions
Chronic Hepatitis B
Interventions
DRUG

TQA3605 tablets Placebo

Placebo contains no active substance.

DRUG

TQA3605 Tablets

TQA3605 tablets is core protein allosteric modulators

DRUG

Entecavir dispersible tablets

Entecavir dispersible tablets is an inhibitor of hepatitis B virus replication.

Trial Locations (29)

100015

Beijing Ditan Hospital Capital Medical University, Beijing

100069

Beijing Youan Hospital,Capital Medical University, Beijing

130021

The First Hospital of Jilin University, Changchun

200000

Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

200336

Shanghai Tongren Hospital, Shanghai

210003

Jiangsu Provincial People's Hospital, Nanjing

The Second Hospital of Nanjing, Nanjing

210008

Naniing Drum Tower Hospital, Nanjing

212004

Zhenjiang Third People's Hospital, Zhenjiang

214061

The Fifth People's Hospital of Wuxi, Wuxi

215131

The Fifth People's Hospital of Suzhou, Suzhou

250033

The Second Hospital of Shandong University, Jinan

250102

Shandong Provincial Clinical Center for Public Health, Jinan

322099

Yiwu Central Hospital, Yiwu

330000

The First Affiliated Hospital of Nanchang University, Nanchang

350025

Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou

400010

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

400038

The Southwest Hospital of AMU, Chongqing

410005

The First Hospital of Changsha, Changsha

450000

Zhengzhou No.6 peoples Hospital, Zhengzhou

450002

Henan Provincial People's Hospital, Zhengzhou

510515

NanFang Hospital, Guangzhou

518036

Peking University Shenzhen Hospital, Shenzhen

530021

The First Affiliated Hospital of GUANGXI Medical University, Nanning

710000

The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an

Xi'an Jiaotong University Second Affiliated Hospital, Xi'an

830013

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

050000

Hebei Medical University Third Hospital, Shijiazhuang

Liaoning

Shengjing Hospital Affiliated to China Medical University, Shenyang

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY